AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPhenomena and ProcessesDisciplines and OccupationsTechnology, Industry, AgricultureInformation ScienceHealth Care
ImmunophenotypingLymphomaLymphoma, B-CellLymphoma, Non-HodgkinLymphoma, T-CellLymphoma, Large B-Cell, DiffuseLymphoma, FollicularBurkitt LymphomaFlow CytometryLymphoma, Mantle-CellLymphoma, B-Cell, Marginal ZoneLymphoma, T-Cell, CutaneousLymphoma, T-Cell, PeripheralLymphoma, AIDS-RelatedAntigens, CD20Lymphoma, Large-Cell, AnaplasticHodgkin DiseaseAntigens, CDLaser Scanning CytometryLeukemiaAntigens, CD7Antigens, CD5B-LymphocytesLeukemic InfiltrationTranslocation, GeneticPseudolymphomaIn Situ Hybridization, FluorescenceAntigens, CD19Lymphoma, Large-Cell, ImmunoblasticAntibodies, MonoclonalChromosomes, Human, Pair 14ImmunohistochemistryTumor Markers, BiologicalBone MarrowMycosis FungoidesLymphocyte SubsetsLeukemia, Lymphocytic, Chronic, B-CellNeprilysinPrognosisHematologyLymphoproliferative DisordersAntigens, CD45Leukemia, Prolymphocytic, T-CellLymph NodesGene RearrangementVincristineLeukemia-Lymphoma, Adult T-CellPrecursor Cell Lymphoblastic Leukemia-LymphomaImage CytometryHematologic NeoplasmsAntibodies, Monoclonal, Murine-DerivedAntigens, CD3Lymphatic DiseasesCD4-CD8 RatioAntigens, NeoplasmPrednisoneT-LymphocytesGene Rearrangement, gamma-Chain T-Cell Antigen ReceptorLeukemia, Hairy CellAntineoplastic Combined Chemotherapy ProtocolsNeoplasm, ResidualRetrospective StudiesAntigens, SurfaceSkin NeoplasmsBiopsy, NeedleBone Marrow ExaminationImmunoglobulin Heavy ChainsCell SeparationLymphoma, Extranodal NK-T-CellAntigens, CD56BiopsyPolymerase Chain ReactionCyclophosphamidePhenotypeImmunoenzyme TechniquesLymphocyte CountImmunoglobulin Light ChainsLeukemia, Myeloid, AcuteClone CellsKaryotypingDoxorubicinLymphocytesCytogenetic AnalysisPlasma CellsLeukemia, MyeloidAntigens, Differentiation, B-LymphocyteAcute DiseaseSensitivity and SpecificityAntigens, CD30B-Lymphocyte SubsetsTreatment OutcomeSplenic NeoplasmsHerpesvirus 4, HumanChromosome AberrationsAntigens, CD8Chromosomes, Human, Pair 18Antigens, CD34Survival AnalysisDog DiseasesDNA, Neoplasm
Follicular lymphomaLeukemiaHodgkinDiagnosisBiopsyHodgkin'sMalignantCutaneousBoneDiffuseTumorsCell lymphomaLeukemias and lymphomasCytometricLymphocytesHuman lymphomasBurkittMantleLymphatic systemCanine LymphomaType of lymphomaForms of lymphomaTypes of lymphomaCellsSubtypesExtranodalClinicalEtiologyLymphoidAggressiveTherapiesPrognosticCancerCancersOncologyIncidenceRelapse
Follicular lymphoma10
  • Follicular lymphoma, low-power view. (medscape.com)
  • Follicular lymphoma is a type of non-Hodgkin lymphoma that most commonly presents as a painless, slowly progressive adenopathy. (medscape.com)
  • Because the chromosomal t(14;18) translocation is found in the majority of patients with follicular lymphoma, bone marrow aspiration and chromosome analysis can also help establish the diagnosis. (medscape.com)
  • Most patients with follicular lymphoma present at an advanced stage, and most patients have bone marrow involvement at diagnosis. (medscape.com)
  • Clinically, grade 3B follicular lymphoma is treated like diffuse large B-cell lymphoma . (medscape.com)
  • Multiagent chemotherapy in combination with rituximab is the most common first-line treatment strategy for follicular lymphoma. (medscape.com)
  • This enabled identification of TFs that can be uniquely associated to the tumor cells of chronic lymphocytic leukemia (CLL), diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), hairy cell leukemia (HCL), and mantle cell lymphoma (MCL). (lu.se)
  • CAR T-cell therapy is currently being used at Winship for patients with relapsed or refractory B-cell lymphomas, including diffuse large B-cell lymphoma, mantle cell lymphoma, and follicular lymphoma. (emory.edu)
  • A study to evaluate the safety and efficacy of duvelisib administered in combination with rituximab vs placebo in combination with rituximab in patients with previously treated CD20-positive follicular lymphoma who are not suitable candidates for chemotherapy. (clincosm.com)
  • Study IPI-145-08 is an international, multicenter, randomized, double-blind, placebo-controlled, parallel-group, Phase 3 study designed to evaluate the efficacy and safety of duvelisib in combination with rituximab vs placebo in combination with rituximab in subjects with previously treated CD20-positive follicular lymphoma. (clincosm.com)
Leukemia14
Hodgkin37
  • Hodgkin lymphoma (HL) may be difficult to diagnosis. (lls.org)
  • Due to the low abundance of Reed-Sternberg cells, performing genetic analysis from tumor samples in Hodgkin lymphoma can be difficult. (lls.org)
  • Once your hematologist-oncologist confirms a Hodgkin lymphoma diagnosis, he or she orders more tests to stage your disease . (lls.org)
  • Role of Flow Cytometric Immunophenotyping for Classic Hodgkin Lymphoma in Small Biopsy and Cytology Specimens. (cornell.edu)
  • The diagnosis of classic Hodgkin lymphoma (CHL) traditionally requires surgical tissue biopsy because of the paucity of diagnostic Hodgkin and Reed-Sternberg cells. (cornell.edu)
  • Accurate and precise diagnosis of non-Hodgkin lymphoma helps doctors choose the best course of treatment plans for their patients. (mdanderson.org)
  • At MD Anderson, our group of experts is among the most experienced and skilled in the nation in diagnosing non-Hodgkin lymphoma. (mdanderson.org)
  • If you have symptoms that may signal non-Hodgkin lymphoma, your doctor will examine you and ask you questions about your health and your medical history. (mdanderson.org)
  • If you have been diagnosed with non-Hodgkin lymphoma, certain blood tests may help doctors determine your outlook. (mdanderson.org)
  • Immunophenotyping: Cells from a lymph node, blood or bone marrow are examined with a microscope to determine what type of non-Hodgkin lymphoma cells are present. (mdanderson.org)
  • If you are diagnosed with non-Hodgkin lymphoma, your doctor will determine the stage (or extent) of the disease. (mdanderson.org)
  • If the cancer is in one organ outside the lymph node such as the skin, lung, brain, etc., this is called extension, or E non-Hodgkin lymphoma. (mdanderson.org)
  • one of the most curable blood cancers, but less common than non-Hodgkin lymphoma. (emory.edu)
  • There are many types of non-Hodgkin lymphoma and it may be slow growing (indolent) or fast growing (aggressive). (emory.edu)
  • A form of non-Hodgkin lymphoma having a usually diffuse pattern with both small and medium lymphocytes and small cleaved cells. (lookformedical.com)
  • It accounts for about 5% of adult non-Hodgkin lymphomas in the United States and Europe. (lookformedical.com)
  • Non-Hodgkin lymphomas (NHLs) are a biologically and clinically diverse group of lymphoproliferative disorders. (adamondemand.com)
  • MCL represents 2-10% of all non-Hodgkin lymphomas. (medscape.com)
  • BACKGROUND: Hodgkin lymphoma (HL) is a highly curable malignant tumor. (bvsalud.org)
  • Session 4 of the 2021 European Association of Haematopathology/Society for Hematopathology Workshop focused on nodular lymphocyte predominant Hodgkin lymphoma (NLPHL). (bvsalud.org)
  • First, the spectrum of immunophenotypic variations in NLPHL and the defining criteria for classic Hodgkin Lymphoma (CHL) were discussed. (bvsalud.org)
  • Non-Hodgkin lymphoma (NHL) represents a heterogeneous group of malignancies of different biology and prognosis. (medscape.com)
  • The term non-Hodgkin lymphoma (NHL) encompasses a heterogeneous mix of lymphomas, which are either of a B- or T-cell phenotype and that meet the diagnostic criteria for one of the subtypes detailed in the 2008 World Health Organization (WHO) Classification of Tumours of Haematopoietic and Lymphoid Tissues. (medscape.com)
  • Go to Malignant Lymphoma and Non-Hodgkin Lymphoma for complete information on these topics. (medscape.com)
  • Primary non-Hodgkin lymphoma (NHL) of bone can be a difficult to diagnosis without a high level of suspicion. (medscape.com)
  • Anemia and/or elevated lactate dehydrogenase (LDH), alkaline phosphatase (ALP), erythrocyte sedimentation rates (ESRs), platelet counts, and calcium levels have been reported with primary non-Hodgkin lymphoma (NHL) of bone. (medscape.com)
  • 9] The radiologic differential diagnosis includes benign entities (reactive conditions, osteomyelitis) and malignant entities (Hodgkin lymphoma, sarcoma, neuroblastoma, metastatic disease). (medscape.com)
  • Grossly the lesions of primary non-Hodgkin lymphoma (NHL) of bone are usually yellow-tan and fleshy in appearance. (medscape.com)
  • Non-Hodgkin lymphomas are a heterogeneous group of disorders involving malignant monoclonal proliferation of lymphoid cells in lymphoreticular sites, including lymph nodes, bone marrow, the spleen, the liver, and the gastrointestinal tract. (msdmanuals.com)
  • The major types are Hodgkin lymphoma Non-Hodgkin lymphoma See table Comparison of Hodgkin. (msdmanuals.com)
  • Hodgkin Lymphoma Hodgkin lymphoma is a localized or disseminated malignant proliferation of cells of the lymphoreticular system, primarily involving lymph node tissue, spleen, liver, and bone marrow. (msdmanuals.com)
  • Non-Hodgkin lymphoma is not one disease but rather a category of lymphocyte cancers with a number of subgroups largely divided into aggressive and indolent types. (msdmanuals.com)
  • Non-Hodgkin lymphoma is the 2nd most common cancer in HIV-infected patients Non-Hodgkin lymphoma AIDS-defining cancers in patients infected with HIV are Kaposi sarcoma Lymphoma, Burkitt (or equivalent term) Lymphoma, immunoblastic (or equivalent term) Lymphoma, primary, of central nervous system read more , and some AIDS patients present with lymphoma. (msdmanuals.com)
  • Indeed, patients with non-Hodgkin lymphoma should generally be screened for HIV and hepatitis viruses. (msdmanuals.com)
  • Also, patients with a first-degree relative with Hodgkin or non-Hodgkin lymphoma have an increased risk of non-Hodgkin lymphoma. (msdmanuals.com)
  • ABSTRACT In view of the widespread use of pesticides in Egypt and the increasing incidence of leukaemia and lymphoma we aimed to assess pesticide exposure and other selected variables as risk factors for lymphoproliferative disorders (leukaemia and non-Hodgkin lymphoma). (who.int)
  • The risk was significant for cases of non-Hodgkin lymphoma but not chronic lymphocytic leukaemia. (who.int)
Diagnosis14
  • Despite the fact that most follicular lymphomas are advanced at the time of diagnosis, many patients may not require treatment for prolonged periods of time, and the median survival of patients with follicular lymphomas has historically been approximately 8-10 years. (medscape.com)
  • Biopsy is essential to establish a diagnosis of lymphoma. (medscape.com)
  • A doctor will carry out several tests to confirm a non-Hodgkin's lymphoma diagnosis. (healthline.com)
  • A lymphoma diagnosis often includes imaging tests. (healthline.com)
  • The differential diagnosis includes other cutaneous lymphomas, particularly the cutaneous nasal type T/natural killer-cell lymphoma, mycosis fungoides, precursor T-cell lymphoblastic lymphoma, nonspecific peripheral T-cell lymphoma, cutaneous anaplastic large cell lymphoma, and subcutaneous panniculitic T-cell lymphoma. (nih.gov)
  • Diagnosis of lymphoma is done with a biopsy, which involves examination by a pathologist of tissue or cells obtained by removing all or part of a lymph node. (emory.edu)
  • 3 - 5 This report by the Spanish Lymphoma Group (GELTAMO) aims to provide useful guidelines and recommendations for the prevention, diagnosis, and treatment of central nervous system diffuse large B-cell lymphoma patients with, or at risk of, leptomeningeal and/or brain parenchyma lymphoma relapse. (haematologica.org)
  • Applied together with other ancillary techniques, such as flow cytometry (FC), FNB is a potential tool for the diagnosis of lymphomas, and enlarged lymph nodes represent an excellent target for the implementation of this technique. (karger.com)
  • Confirmation of diagnosis and immunophenotype in acute and chronic leukemias and lymphomas. (umich.edu)
  • Measurement of TdT may be an adjunct to the diagnosis of some leukemias and lymphoblastic lymphomas and will be run at the discretion of the hematopathologist at an additional charge. (umich.edu)
  • Genomic signatures in T-cell lymphoma: How can these improve precision in diagnosis and inform prognosis? (nebraska.edu)
  • but given no improvement was observed, a second cervicotomy was performed, with the histopathological diagnosis of the latter of Hodgkin's lymphoma. (bvsalud.org)
  • Based on a large collection of cases, the defining morphological, immunophenotypical, and gene expression features of T-cell/histiocyte-rich large B-cell lymphoma (THRLBCL) and THRLBCL-like NLPHL (pattern E) were reviewed to explore this challenging differential diagnosis and critically evaluate whether aggressive behavior and transformation of NLPHL can be predicted in practice. (bvsalud.org)
  • Fast Facts: Cutaneous T-Cell Lymphoma' is designed to help primary care providers, dermatologists, and oncologists to communicate effectively with pathologists in the diagnosis of this chronic condition, aided by over 100 superb clinical and pathological images, and to provide tailored long-term care for their patients. (ebookmedicine.com)
Biopsy2
Hodgkin's9
Malignant9
  • Immunophenotyping and expression profiling suggested that p73 loss allowed increased maturation of malignant B cells and deregulated genes involved in lymphocyte homing and dissemination of human lymphomas. (jci.org)
  • A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. (lookformedical.com)
  • Malignant lymphoma composed of large B lymphoid cells whose nuclear size can exceed normal macrophage nuclei, or more than twice the size of a normal lymphocyte. (lookformedical.com)
  • Most of these lymphomas represent the malignant counterpart of B-lymphocytes at midstage in the process of differentiation. (lookformedical.com)
  • Malignant lymphoma in which the lymphomatous cells are clustered into identifiable nodules within the LYMPH NODES. (lookformedical.com)
  • A group of lymphomas exhibiting clonal expansion of malignant T-lymphocytes arrested at varying stages of differentiation as well as malignant infiltration of the skin. (lookformedical.com)
  • A group of malignant lymphomas thought to derive from peripheral T-lymphocytes in lymph nodes and other nonlymphoid sites. (lookformedical.com)
  • This study may result in novel therapies for lymphoma based on selective inhibition of the elements of the IL-2R signal transduction pathway(s) which are preferentially utilized by malignant T cells and/or on induction of re-expression of the epigenetically-silenced SHP-1 gene. (upenn.edu)
  • Go to Malignant Lymphoma for complete information on this topic. (medscape.com)
Cutaneous2
  • Hydroa-like cutaneous T-cell lymphoma (hydroa-like CTCL) is an unusual pediatric malignancy with a poor prognosis. (nih.gov)
  • We found that cutaneous T-cell lymphoma cells display activation of the interleukin-2 receptor/cytokine common chain-associated Jak/STAT signal transduction pathway that is transient in the early stage of the lymphoma and constitutive in the late stage of the disease progression. (upenn.edu)
Bone10
Diffuse2
  • In search for subgroups of diffuse large B-cell lymphoma (DLBCL) with different histogenetic origin and prognosis, as has been described by gene expression profiling, we examined tumor specimens from 125 patients with DLBCL, uniformly treated by either cyclophosphamideAdriamycin-vincristine-prednisone or methotrexate, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin in a multicenter trial set by the Nordic Lymphoma Group 1989-1994. (aacrjournals.org)
  • Several factors hinder the identification of risk factors for central nervous system (CNS) involvement in diffuse large B-cell lymphoma (DLBCL), including the retrospective nature of most studies, the relatively low frequency of CNS relapse in DLBCL, and the heterogeneity of CNS prophylaxis methods used in these studies. (haematologica.org)
Tumors3
  • B-cell lymphomas (BCLs) constitute a diverse set of tially identify new functional, diagnostic, and therapeutic tumors, both morphologically and clinically, that are mainly targets. (lu.se)
  • Consistent with this, p73 expression was frequently downregulated in a large cohort of human mature aggressive B cell lymphomas, and both the incidence and degree of p73 downregulation in these tumors correlated with their extranodal dissemination status. (jci.org)
  • Overview of Lymphoma Lymphomas are a heterogeneous group of tumors arising in the reticuloendothelial and lymphatic systems. (msdmanuals.com)
Cell lymphoma10
  • The T cell form of lymphoma is less responsive the therapy, and has a worse long term prognosis than B cell lymphoma. (vin.com)
  • These data indicate that p73 is a modifier of Myc-driven lymphomas in mice, favoring tumor dissemination, and suggest that p73 could be a biomarker for human B cell lymphoma dissemination, a notion that can now be tested in clinicopathologic correlation studies. (jci.org)
  • However, the histologic and immunophenotypic features of angioimmunoblastic T-cell lymphoma at this site are poorly defined. (umn.edu)
  • By contrast, programed death-1 immunohistochemical staining and double labeling using antibodies specific for BCL-6 and CD3 were helpful in appreciating the follicular T-helper cell immunophenotype of angioimmunoblastic T-cell lymphoma. (umn.edu)
  • The novel genetic information gained from genome-wide high throughput techniques has greatly improved our understanding of peripheral T-cell lymphoma (PTCL). (nebraska.edu)
  • Mantle cell lymphoma (MCL) is a lymphoproliferative disorder derived from a subset of naive pregerminal center cells localized in primary follicles or in the mantle region of secondary follicles. (medscape.com)
  • B-cell receptor (BCR) and co-receptor CD40 signaling is essential for normal B cells, and there is increasing evidence that signaling via BCR and CD40 plays an important role in the pathogenesis of B-cell lymphoma. (biomedcentral.com)
  • 1. Role of the cytokine-signal transduction pathways and epigenetic gene silencing in pathogenesis of T-cell lymphoma. (upenn.edu)
  • These findings indicate that TOR inhibitors such as RAD may be effective in prevention and treatment of PTLDs and, possibly, other types of B-cell lymphoma. (upenn.edu)
  • Accumulating evidence indicates that expression of anaplastic lymphoma kinase (ALK) defines a distinct type of T-cell lymphoma. (upenn.edu)
Leukemias and lymphomas1
  • Our research focuses on developmental pathways that regulate hematopoietic cell growth and differentiation and are disrupted in the course of neoplastic transformation, particularly in leukemias and lymphomas. (stanford.edu)
Cytometric1
Lymphocytes4
  • A needle aspirate of the typical, canine 'virgin' lymphoma typically consists of a pure population of immature lymphocytes (a homogenous population of round, mononuclear cells). (vin.com)
  • Lymphoma is a cancer that occurs when your body's white blood cells, called lymphocytes, begin behaving abnormally. (emory.edu)
  • Differentiating between low-grade lymphoma and reactive lymphocytes is often difficult by morphology alone as reactive lymphoid cells may acquire activation morphology from being exposed to different cytokines within the body fluid. (cytojournal.com)
  • Clinical Applications of Flow Cytometry: Quality Assurance and Immunophenotyping of Lymphocytes: Approved Guideline. (bdbiosciences.com)
Human lymphomas1
  • Aberrant cell signaling and epigenetic regulation of gene expression in human lymphomas. (upenn.edu)
Burkitt1
Mantle1
  • The majority of mantle-cell lymphomas are associated with a t(11;14) translocation resulting in overexpression of the CYCLIN D1 gene (GENES, BCL-1). (lookformedical.com)
Lymphatic system3
  • Lymphoma occurs if cancer forms in the lymphatic system. (healthline.com)
  • The cancer specialists at Scripps MD Anderson Cancer Center are experts in caring for people with lymphoma, or cancer that affects the lymphatic system. (scripps.org)
  • Lymphoma is a cancer that starts in cells found in the lymphatic system, which is part of the immune system. (scripps.org)
Canine Lymphoma2
  • Canine lymphoma is usually a malignancy of immature cells (lymphoblasts). (vin.com)
  • Canine lymphoma comprises approximately 7-24% of all canine neoplasia and 83% of canine hematopoietic malignancies. (dvm360.com)
Type of lymphoma4
  • The sample may also help your doctor determine the type of lymphoma and how fast it's growing. (healthline.com)
  • Our blood cancer experts will determine your specific type of lymphoma and develop a treatment plan that targets your cancer most effectively. (emory.edu)
  • Diagnosing your particular type of lymphoma is a crucial part of providing you with the right treatment. (emory.edu)
  • Each type of lymphoma is sensitive to different combinations of chemotherapy, which may involve one or a combination of anticancer drugs that destroy cancer cells. (emory.edu)
Forms of lymphoma1
Types of lymphoma1
Cells7
  • Lymphoma cells were mostly of intermediate size with dense hyperchromatic nuclei, inconspicuous nucleoli, and infrequent mitosis. (nih.gov)
  • The lymphoma cells displayed T-cell cytotoxic phenotype. (nih.gov)
  • Since the '90s immunophenotyping (staining cells with antibodies conjugated with fluorochromes and detection with flow cytometer) became the preferred method in diagnostics of haematological malignancies. (wikipedia.org)
  • While most lymphomas arise from B cells, a subset will arise from T cells. (vin.com)
  • Mice engineered to express c-Myc in B cells (Eμ-myc mice) develop lethal lymphomas in which the gene encoding the p53 tumor suppressor is frequently mutated. (jci.org)
  • It reacts with the majority of B-cells present in peripheral blood and lymphoid tissues and their derived lymphomas. (biogenex.com)
  • Similarly, CD40L-induced p-ERK and p-p38 were also significantly reduced in lymphoma B cells, whereas p-p65 (NF-κB) was equal to that of normal B cells. (biomedcentral.com)
Subtypes1
  • Chromosome abnormalities are being described more frequently, and serve as markers, and in some cases prognostic factors, for subtypes of several lymphomas in human medicine. (dvm360.com)
Extranodal1
Clinical2
  • PTCL consists of numerous distinct entities and is currently diagnosed using a combination of clinical and morphologic features and immunophenotyping together with limited molecular assays leading to an often fragmented, complicated diagnostic system. (nebraska.edu)
  • The Working Formulation, originally proposed in 1982, classified and grouped lymphomas by morphology and clinical behavior (ie, low, intermediate, or high grade) with 10 subgroups labeled A to J.{Ref 1} In 1994, the Revised European-American Lymphoma (REAL) classification attempted to apply immunophenotypic and genetic features in identifying distinct clinicopathologic NHL entities. (medscape.com)
Etiology1
  • Lymphoma is a very diverse group of neoplasms whose etiology remains largely unknown. (dvm360.com)
Lymphoid1
  • Many of the sites of these lymphomas, such as the stomach, salivary gland, and thyroid, are normally devoid of lymphoid tissue. (lookformedical.com)
Aggressive1
  • With few exceptions, stem cell transplantation is usually reserved for patients with aggressive lymphomas after incomplete remission or relapse. (msdmanuals.com)
Therapies3
  • Our lymphoma doctors diagnose and treat lymphomas using many of the latest technologies, including advanced chemotherapy, immunotherapy and highly targeted radiation therapies. (scripps.org)
  • As a lymphoma patient, you want to know you're getting the full range of treatment options and the most current, targeted therapies available. (emory.edu)
  • At Winship, we're leaders in translating research breakthroughs into effective therapies for lymphoma patients and can offer you an individualized care plan that incorporates the best treatments available. (emory.edu)
Prognostic1
  • Greater than 50% infiltration of lymphoma within the marrow is a poor prognostic factor. (vin.com)
Cancer3
  • High levels in the blood may be a sign of cancer, including lymphoma, but could also be due to other sources of inflammation. (healthline.com)
  • In fact, we are one of the few cancer centers with hematopathologists, specialized doctors who focus on diagnosing lymphoma and other blood cancers, on your care team. (mdanderson.org)
  • When you come to Winship Cancer Institute for lymphoma treatment, you have a multidisciplinary team of experts dedicated to your well-being. (emory.edu)
Cancers1
Oncology1
  • Our multidisciplinary lymphoma care teams include hematologists, pathologists, radiologists, advanced practice nurses, and oncology nurses who have decades of experience and can provide a comprehensive and coordinated approach to treating lymphoma. (emory.edu)
Incidence1
  • [ 2 ] No sex preponderance is seen for follicular lymphomas, but the incidence increases with age and varies across racial groups. (medscape.com)
Relapse1
  • Several studies 10 7 5 4 and a recent meta-analysis 1 have described a decrease in rates of CNS relapse in the post-rituximab era (probably due to improved control of systemic lymphoma), in addition to a change in the pattern of CNS relapse, with predominance of parenchymal over leptomeningeal relapse, isolated over combined (systemic plus CNS) relapses, and delayed CNS relapses. (haematologica.org)